FREELINE THERAPEUTICS LTD has a total of 24 patent applications. Its first patent ever was published in 2018. It filed its patents most often in United Kingdom, WIPO (World Intellectual Property Organization) and EPO (European Patent Office). Its main competitors in its focus markets biotechnology, pharmaceuticals and foods and drinks are KOCHANEK STEFAN, SHENZHEN BIOCAN TECH CO LTD and REGENESIS SCIENCE CO LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | United Kingdom | 18 | |
#2 | WIPO (World Intellectual Property Organization) | 3 | |
#3 | EPO (European Patent Office) | 2 | |
#4 | United States | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals | |
#3 | Foods and drinks |
# | Technology | |
---|---|---|
#1 | Microorganisms | |
#2 | Medical preparations | |
#3 | Therapeutic chemical compounds | |
#4 | Peptides | |
#5 | Enzymes |
# | Name | Total Patents |
---|---|---|
#1 | Hörer Markus | 5 |
#2 | Kochanek Stefan | 3 |
#3 | Hauser Caroline | 3 |
#4 | Krüger-Haag Alexandra | 3 |
#5 | Kober Renée | 2 |
#6 | Sonntag Florian | 2 |
#7 | Mcintosh Jenny | 1 |
#8 | Corbau Romuald | 1 |
#9 | Kia Azadeh | 1 |
#10 | Nathwani Amit | 1 |
Publication | Filing date | Title |
---|---|---|
GB202100648D0 | Polypeptide | |
GB202016254D0 | Plasmid system | |
GB202011813D0 | Polypeptide | |
GB202009928D0 | Method | |
GB202009741D0 | Polynucleotide | |
GB202006987D0 | Improved assay | |
GB202006250D0 | Factor V111 construct | |
WO2020208379A1 | Plasmid system | |
GB202001496D0 | Improved assay | |
WO2020161483A1 | Polynucleotides | |
GB202001203D0 | Improved assay | |
GB201917925D0 | Factor VIII conctruct | |
GB201917926D0 | Transcription regulatory elements | |
GB201917910D0 | Polynucleotides | |
GB201917927D0 | Factor VIII polypeptide | |
GB201915955D0 | Factor VIII construct | |
GB201915956D0 | Factor viii construct | |
GB201915953D0 | Transcription regulatory elements | |
EP3722434A1 | Plasmid system | |
GB201905263D0 | Plasmid system |